Summary
This study sought to determine the timecourse of development of reduced nerve laser Doppler flux in experimental diabetes and the effect on this anomaly of insulin treatment. In addition, we aimed to compare nerve laser Doppler flux in streptozotocin-and genetically-diabetic BB rat models. Sciatic nerve laser Doppler flux in diabetic rats was variable during the 2 days following streptozotocin injection; from day 4, when the measurement was 80% of control, fluxes fell steadily and formed a plateau at 40% of control values after 4 weeks of diabetes. In a second study, using rats with 4-week streptozotocin-diabetes, sciatic nerve laser Doppler flux was reduced to 44% of the value measured in control rats. Treatment of a parallel group of diabetic rats with insulin, by sustained release implants, prevented this ischaemia, so that nerve laser Doppler flux was 91% of controls. Nerve Doppler flux in BB rats with 6-week genetic diabetes was 57% of a control (non-diabetic) BB group. There were no differences in mean arterial pressures between control and diabetic rats in any of the studies. Heart rates of control and insulin-treated diabetic animals were higher than those of the untreated diabetic group; in the other studies heart rates of diabetic animals were numerically lower than controls, but not significantly so. These observations suggest that sciatic nerves of rats with short-term diabetes, whether induced with streptozotocin or of genetic origin, are markedly ischaemic and that this ischaemia in streptozotocindiabetes is evident within a week of diabetes onset, forms a plateau after 4 weeks and is maintained for at least 2 months. The findings also indicate that treatment of short-term diabetes with insulin can prevent nerve ischaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Carrington AL, Ettlinger CB, Calcutt NA, Tomlinson DR (1991) Aldose reductase inhibition with imirestat — effects on impulse conduction and insulin-stimulation of Na+/K+-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia 34: 397–401
Pirart J (1978) Diabetes mellitus and its degenerative complications; a prospective study of 4400 patients observed between 1947 and 1973. Part 1. Diabetes Care 1: 168–188
Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Part 2. Diabetes Care 1: 252–263
Jennings PE, Barnett AH (1988) New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diab Med 5: 111–117
Tomlinson DR, Willars GB, Carrington AL (1992) Aldose reductase inhibitors and diabetic complications. Pharmacol Ther 54: 151–194
Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Newrick PG, Wilson AJ, Jakubowski JA, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMT 293: 1053–1054
Smith WJ, Diemel LT, Leach RM, Tomlinson DR (1991) Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience 45: 255–259
Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35: 12–18
Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+-K+-ATPase activity, and vascular supply in STZ-D rats. Diabetes 40: 1652–1658
Cameron NE, Cotter MA, Robertson S (1991) Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40: 532–539
Lockett MJ, Tomlinson DR (1992) The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+-K+ pump in streptozotocin-diabetic rats. Br J Pharmacol 105: 355–360
Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR (1993) Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia 36: 397–401
Rasch R (1979) Control of blood glucose levels in the streptozotocin diabetic rat using a long-acting heat-treated insulin. Diabetologia 16: 185–190
Yasuda H, Sonobe M, Yamashita M et al. (1989) Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 38: 832–838
Hotta N, Kakuta H, Fukasawa H et al. (1992) Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Diabetes 41: 587–591
Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA (1991) Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107–6111
Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK (1984) Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81: 6894–6898
Monafo WW, Eliasson SG, Shimazaki S, Sugimoto H (1988) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614
Zochodne DW, Ho LT (1992) Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can J Physiol Pharmacol 70: 651–659
Corbett JA, Tilton RG, Chang K et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556
Sutera SP, Chang K, Marvel J, Williamson JR (1992) Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil. Am J Physiol Heart Circ Physiol 263: H945-H950
Jakobsen J (1978) Peripheral nerves in early experimental diabetes. Diabetologia 14: 113–119
Takeuchi M, Low PA (1987) Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am J Physiol 253: E349-E353
Rundquist I, Smith QR, Michel ME, Ask P, Oberg PA, Rapoport SI (1985) Sciatic nerve blood flow measured by laser Doppler flowmetry and [14C]iodoantipyrine. Am J Physiol 248: 311–317
Lundborg G, Branemark P-I (1968) Microvascular function and structure of peripheral nerves. Adv Microcirc 1: 66–75
Calcutt NA, Ettlinger CB, Carrington AL, Diemel LT, Tomlinson DR (1991) Resistance to hypoxic conduction block in sciatic nerves of rats with streptozotocin-induced diabetes. J Neurol Sci 103: 116–123
Cameron NE, Cotter MA, Robertson S, Maxfield EK (1993) Nerve function in experimental diabetes in rats: effects of electrical stimulation. Am J Physiol Endocrinol Metab 264: E161-E166
McMillan DE (1983) The effect of diabetes on blood flow properties. Diabetes 32: 56–63
Kihara M, Nickander KK, Low PA (1991) The effect of aging on endoneurial blood flow, hyperemic response and oxygenfree radicals in rat sciatic nerve. Brain Res 562: 1–5
Mendell JR, Sahenk Z, Warmolts JR, Marshall JK, Thibert P (1981) The spontaneously diabetic BB Wistar rat. Morphologic and physiologic studies of peripheral nerve. J Neurol Sci 52: 103–115
Ward KK, Low PA, Schmelzer JD, Zochodne DW (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112: 197–208
Kamata K, Miyata N, Kasuya Y (1989) Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614–618
Tomlinson KC, Gardiner SM, Bennett T (1990) Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats. Am J Physiol 258: R852-R859
Tomlinson KC, Gardiner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103–150
Foy JM, Lucas PD (1978) Comparison between spontaneously beating atria from control and streptozotocin-diabetic rats. J Pharm Pharmac 30: 558–562
Pierce GN, Dhalla NS (1983) Sarcolemmal Na + -K + -ATPase activity in diabetic rat heart. Am J Physiol 245: C241-C247
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stevens, E.J., Carrington, A.L. & Tomlinson, D.R. Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia 37, 43–48 (1994). https://doi.org/10.1007/BF00428776
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428776